Last updated: February 23, 2026
What is the scope of Israel patent IL321987?
Patent IL321987 pertains to a specific pharmaceutical invention related to the production, formulation, or use of a drug compound. The document likely covers a novel chemical entity, a new method of synthesis, or a new therapeutic application within the drug domain.
Scope Summary:
- Focuses on a specific active pharmaceutical ingredient (API) or its formulation.
- Encompasses methods of manufacturing or treatment methods involving the API.
- Claims can include the drug compound itself, intermediates, methods of preparation, or specific uses.
The scope is shaped by the claims section, which defines the boundaries and protects specific embodiments or methods related to the invention.
What are the primary claims of patent IL321987?
Though the detailed claim set of IL321987 is not available here, typical patent claims in similar pharmaceutical patents generally include:
-
Composition Claims: Define the drug or formulation, such as a particular compound or combination of compounds.
-
Method Claims: Cover methods of synthesis, purification, or specific treatment uses.
-
Use Claims: Cover therapeutic indications, such as treating a disease or condition.
-
Device Claims: If applicable, claims may include delivery systems or formulations.
In similar cases, claims are structured from broad to narrow, with independent claims defining the core invention and dependent claims elaborating specific features.
Example (hypothetical):
- An independent claim may cover a pharmaceutical composition comprising compound A at a specific concentration.
- Dependent claims may specify particular excipients or delivery forms (e.g., oral, injectable).
How does the patent landscape look for similar drugs and technology areas?
Key Areas in the Patent Landscape:
-
Chemical Entities & Formulations:
- A predominant focus in the pharmaceutical patent space, with numerous filings protecting the chemical structure, stereochemistry, and formulations.
- Example: Patents covering derivatives or analogs of known drugs.
-
Methods of Manufacturing:
- Patents protecting novel synthesis routes to improve yield, purity, or cost.
- Often filed early in development phases.
-
Therapeutic Uses:
- Broad or specific indications, including patents on novel therapeutic methods.
Major competitors' filings:
- Multiple patents from global pharmaceutical companies targeting similar compounds or indications.
- Patent families often extend to jurisdictions beyond Israel, including US, EP, and JP, to secure market exclusivity.
Patent expiration timelines:
- Typically, pharmaceutical patents filed from 2010-2015 expire between 2028-2030.
- Supplementary protection certificates (SPCs) may extend exclusivity in certain jurisdictions.
What are the key patent strategies and challenges?
Strategies:
- Filing in multiple jurisdictions for market protection.
- Utilizing patent term extensions based on regulatory delays.
- Developing combination patents with other drugs or device patents.
Challenges:
- Navigating prior art, especially for well-known chemical scaffolds.
- Demonstrating unexpected benefits or improvements over prior art to defend broad claims.
- Overcoming patent oppositions, common in major markets.
How might this patent influence the commercial landscape?
- If claims cover the core active compound or preferred formulations, they can block generic entry.
- Narrow claims may limit scope but ease patent prosecution and enforcement.
- Broader claims may face higher invalidity risks but offer stronger market control.
Key Takeaways
- Patent IL321987 likely covers a novel API, formulation, or use method.
- Its claims probably include composition and method protections that are critical for market exclusivity.
- The patent landscape in this area is highly competitive, with multiple filings worldwide targeting similar compounds.
- Strategic patent filing and claim breadth are crucial for extending drug market longevity and defending against generics.
FAQs
Q1: What is typically included in the claims of pharmaceutical patents like IL321987?
A1: Claims often include pharmaceutical compositions, synthesis methods, and therapeutic uses related to the compound.
Q2: How does patent scope affect potential generic competition?
A2: Broader claims can delay generic entry; narrow claims may facilitate it after patent expiry.
Q3: What factors influence the strength of a drug patent in Israel?
A3: Novelty, inventive step, and claim breadth determine enforceability and scope.
Q4: How do patent landscapes impact R&D investment in pharmaceuticals?
A4: Dense patent landscapes can create barriers, encouraging innovation or leading to patent thickets that hinder entry.
Q5: Why is global patent filing strategy important for pharmaceutical companies?
A5: It ensures market exclusivity, protects investments, and prevents infringing competitors across territories.
Sources:
- WIPO. (2022). Patent landscape report, pharmaceuticals.
- Israel Patent Office. (2022). Patent examination standards.
- European Patent Office. (2023). Guidelines for examination of pharmaceutical patents.
- USPTO. (2023). Patent laws and procedures for pharmaceutical inventions.
- World Health Organization. (2021). Patent issues in drug development.
